Antidepressant efficacy is the new fake news

August 2, 2018, University of New South Wales
Credit: CC0 Public Domain

Are antidepressants an effective treatment for major depression? According to Professor Gordon Parker AO, a professor of psychiatry at UNSW and the founder of the Black Dog Institute, the answer is irrelevant—because we're asking the wrong question.

In a British Journal of Psychiatry editorial published this month, Parker challenges the findings of several studies that analysed the outcomes of multiple clinical trials of . Collectively, these trials spanned hundreds of thousands of patients who received either antidepressants or placebos to treat a diagnosis of .

The aggregated trial data were interpreted in the earlier studies as indicating that antidepressants were no more effective than placebos, leading to widespread public confusion about the validity of these drugs, while the most recent analysis argued for their effectiveness.

The problem, Parker argues, is that trialling antidepressants against a target condition of major produces, if not guarantees, flawed results. 'Major depression' is an umbrella term that refers to a range of depressive illnesses with varying causes, trajectories and treatment responses, rather than to a single condition.

"The conclusions that these studies have drawn are, in a sense, beside the point," Parker says.

"Basically, the target diagnosis of major depression captures multiple types of depressions—some biological, some psychological, some social—and not all would be expected to respond to medication.

"By bundling those with depression due to social and psychological causes in with the biological conditions, the signal benefits of antidepressant medication are swamped and effectively lost."

Parker likens using an antidepressant to treat all types of depression as equivalent to using a Ventolin inhaler to treat all types of lung conditions, regardless of whether a patient has asthma, where an inhaler may be effective, or pneumonia or a pulmonary embolus, where an inhaler would be ineffective and an entirely different treatment might be required.

"For patients with depression, if you narrow down to those who have a biologically-based depressive sub-type, the antidepressants are distinctly effective," he says.

"For example, biological depression or melancholia shows a 60 per cent response to medication, compared to only a 10 per cent response to placebo. If, however, you include other depressive disorders with no primary biological basis—as occurs, if not dominates, in most studies—antidepressants appear to be ineffective."

Parker's editorial also raises serious questions about the design of antidepressant clinical trials, in which patients with serious conditions—such as suicidal ideation, drug and alcohol problems or personality disorders—are ruled out in favour of those with mild symptoms.

Despite meeting the major depression criteria, these low-acuity participants are highly likely to go into spontaneous remission or to respond to placebos, thereby skewing the trial results and subsequent analyses of a drug's efficacy.

"This approach doesn't respect the real world, where there are multiple types of depressive ," Parker says.

"It should not be a simplistic question—are antidepressants effective or ineffective? No treatment should be tested as if it has universal application for multiple differing depressive disorders."

"It's all about saying, what are the circumstances in which they're effective, and when are they irrelevant?"

The editorial was published on August 1 in The British Journal of Psychiatry, Volume 213/Issue 2.

Explore further: Study identifies a link between antidepressant treatment resistance and inflammation

More information: Gordon Parker. The benefits of antidepressants: news or fake news?, The British Journal of Psychiatry (2018). DOI: 10.1192/bjp.2018.98

Related Stories

Study identifies a link between antidepressant treatment resistance and inflammation

June 11, 2018
Researchers at Emory University have found that depressed patients who have not responded to multiple antidepressants exhibit evidence of increased inflammation. Findings were recently published online in the journal, Psychoneuroendocrinology.

How the DSM-5 has come to grief

April 3, 2013
(Medical Xpress)—Widespread confusion about what constitutes grief, 'normaI' depression and clinical depression risks being exacerbated under the American Psychiatry Association's newest classification system, professor ...

New study on the placebo effect and antidepressants in children and adolescents

September 15, 2017
Although the clinical efficacy of antidepressants in children and adolescents is proven, it is frequently accompanied by side effects. In addition, the influence of the placebo effect on the efficacy of antidepressants is ...

Better prediction for effectiveness of paroxetine

April 13, 2017
A third of patients with depression do not respond to the first antidepressant medication prescribed. Currently, the only approach available is one of trial and error. In this study, Max Planck scientists have identified ...

Antidepressants beneficial for women with postnatal depression

May 19, 2015
Antidepressants are associated with better rates of treatment response and remission for women with postnatal depression, when compared to a placebo, according to a new systematic review by the Institute of Psychiatry, Psychology ...

No treatment difference between some antidepressants and CBT for severe depression

December 8, 2015
The available evidence suggests no difference in treatment effects of second generation antidepressants and cognitive behavioral therapy (CBT) either alone or in combination, for patients with major depressive disorder, finds ...

Recommended for you

Schadenfreude sheds light on darker side of humanity

October 23, 2018
Schadenfreude, the sense of pleasure people derive from the misfortune of others, is a familiar feeling to many—perhaps especially during these times of pervasive social media.

Is big-city living eroding our nice instinct?

October 23, 2018
A new study by University of Miami psychology researchers of anonymous interactions suggests that humans switch off their automatic inclination to share in dealings with strangers.

Does putting the brakes on outrage bottle up social change?

October 23, 2018
While outrage is often generally considered a hurdle in the path to civil discourse, a team of psychologists suggest outrage—specifically, moral outrage—may have beneficial outcomes, such as inspiring people to take part ...

Brain training app helps reduce OCD symptoms, study finds

October 23, 2018
A 'brain training' app developed at the University of Cambridge could help people who suffer from obsessive compulsive disorder (OCD) manage their symptoms, which may typically include excessive handwashing and contamination ...

Closing the gender gap in competitiveness with a psychological trick

October 23, 2018
Women are still disadvantaged in society, particularly professionally. They are frequently paid less than men and find it more difficult to have a successful career. One reason for this may be the fact that women are observed ...

First impressions count, new speech research confirms

October 22, 2018
Human beings make similar judgements of the trustworthiness and dominance of an unfamiliar speaker after hearing just a single word, new research shows, suggesting the old saying that 'first impressions count' might well ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Aug 03, 2018
And then there is 'depression' which is really un-diagnosed 'bipolar' which may 'spontaneously' resolve...
Who'd be a medical trials statistician ??

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.